Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 47 , ISSUE 1 ( January-March, 2013 ) > List of Articles


Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment

Vishal Sharma, Surinder Singh Rana, Deepak Kumar Bhasin

Citation Information : Sharma V, Rana SS, Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013; 47 (1):54-60.

DOI: 10.5005/jp-journals-10028-1056

Published Online: 00-03-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


How to cite this article

Rana SS, Sharma V, Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013;47(1):54-60.

PDF Share
  1. Updated population-based review of carcinoid tumors. Ann Surg 2004;240:117-22.
  2. One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-72.
  3. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver 2012;6:405-10.
  4. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012;61:6-32.
  5. Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography. Rev Esp Enferm Dig 2006;98:828-36.
  6. The role of endoscopic ultrasonography in the diagnosis and management of pancreatic cancer. Gastroenterol Clin North Am 2012;41:179-88.
  7. Levels of evidence in endoscopic ultrasonography: A systematic review. Dig Dis Sci 2012;57:602-09.
  8. EUS for pancreatic neuroendocrine tumors: A single-center, 11-year experience. Gastrointest Endosc 2010;71:1185-93.
  9. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography and angiography. Gastroenterology 1992;102:188-99.
  10. Localization of islet cell tumors by endoscopic ultrasonography. Gastroenterology 1992;103:711-12.
  11. Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-51.
  12. Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: A single-centre retrospective study. Clin Nucl Med 2010;35:321-28.
  13. Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 1999;10:139-50.
  14. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 2003;58:531-35.
  15. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008;34:525-32.
  16. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951-59.
  17. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 2007;31:238-41.
  18. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: A study of 48 cases. Cancer 2008;114:255-62.
  19. The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: A study by endoscopic ultrasound-guided fine-needle aspiration cytology. Cancer 2009;117:211-16.
  20. Carcinoid tumors of the gastrointestinal tract: Evaluation with endoscopic ultrasonography. Gastrointest Endosc 1993;39:375-83.
  21. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis Colon Rectum 2005;48:285-91.
  22. Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig 2004;96:847-55.
  23. Usefulness of endoscopic submucosal dissection for the treatment of rectal carcinoid tumors. Eur J Gastroenterol Hepatol 2012;24:770-74.
  24. Endoscopic submucosal dissection for rectal carcinoid tumors. Surg Endosc 2010;24:504-08.
  25. Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg 2011;35:1879-86.
  26. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009;15:2177-83.
  27. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf) 2002;56:557-59.
  28. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006;63:1059-62.
  29. Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy 2011;43(Suppl 2)UCTN:E328-29.
  30. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg 2008;71:333-37.
  31. Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. Endoscopy 2008 Sep;40(Suppl 2):E83.
  32. US-guided ethanol ablation of insulinomas: A new treatment option. Gastrointest Endosc 2012;75:200-06.
  33. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61-72.
  34. Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors. J Chir (Paris) 2005;142:132-49.
  35. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 2006;7:150-56.
  36. Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007;21:87-109.
  37. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001;81:511-25.
  38. Neuroendocrine tumors. J Natl Compr Canc Netw 2012;10:724-64.
  39. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. Ann Oncol 1999;10(Suppl 2):S31-38.
  40. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: A prospective study in 39 patients. Gut 1996;39:279-83.
  41. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111-14.
  42. Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours. Eur J Cancer 1992;28A:1647-50.
  43. Combination therapy with octreotide and alphainterferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999; 94:1381-87.
  44. Eastern Cooperative Oncology G. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 2005;23:4897-904.
  45. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81:1351-55.
  46. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab 2007;21:163-72.
  47. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364: 514-23.
  48. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501-13.
  49. Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 2008;26:1316-23.
  50. Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007;21:111-29.
  51. Treatment of neuroendocrine tumor liver metastases. Int J Hepatol 2012:973-946.
  52. Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation 1998;66: 1307-12.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.